Clinical Trials Browser

Phase 2 × Not yet recruiting × Abiraterone Acetate × Clear all

NCT06500247 2024-07-15

Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Phase 2 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms